Brief: U.S. Federal Trade Commission Says It Has Concerns About Novo Nordisk Bid For Metsera - FTC Letter To Metsera
05/11/2025 19:28
Novo Nordisk A/S NOVOb.CO: U.S. FEDERAL TRADE COMMISSION SAYS IT HAS CONCERNS ABOUT NOVO NORDISK BID FOR METSERA - FTC LETTER TO METSERA FTC IS CONCERNED ABOUT NOVO-METSERA DEAL PROCEEDING WITHOUT FILING FOR HART-SCOTT-RODINO ANTITRUST CLEARANCE FTC SAYS IT HAS NO POSITION ON WHETHER THE PROPOSED NOVO-METSERA TRANSACTION ABIDES BY ANTITRUST LAW US SAYS STRUCTURE OF NOVO NORDISK TRANSACTION MAY REDUCE METSERA'S INCENTIVE TO CONTINUE BRINGING DRUGS TO MARKET
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up